LifeMD, Inc. is a provider of virtual healthcare services and pharmacy services. The Company offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across 200 conditions, including primary care, men’s and women’s health, mental health, and weight management. Its Telehealth platform is end-to-end virtual healthcare directly to consumers and through select enterprise partnerships. In addition, the Company is focused on developing its Rex MD product portfolio, which is primarily focused on asynchronous men’s healthcare, e-pharmacy solutions, and men’s hormonal health. The Company owns a vertically integrated, proprietary digital care platform, a 50-state affiliated medical group, a state-of-the-art affiliated compounding pharmacy, and a United States based patient care center.

Events Timeline

(ET)

2026-01-06

08:50:00

LifeMD Closes $50M Credit Facility with Citizens Bank

2026-01-05 (ET)

2026-01-05

08:40:00

LifeMD Launches Novo Nordisk's Wegovy Pill Starting at $149 per Month

2025-11-17 (ET)

2025-11-17

16:10:41

LifeMD Revises FY25 Revenue Forecast Downward to $192M-$193M from Previous Estimate of $250M-$255M

2025-11-17

16:08:44

LifeMD Reports Q4 Revenue Between $45M and $46M, Below Consensus Estimate of $63.07M

2025-11-17

16:07:37

LifeMD Announces Q3 Earnings Per Share of 10 Cents, Exceeding Consensus Estimate of 5 Cents

News

7.0

01-28Globenewswire

LifeMD Executives Allegedly Breached Fiduciary Duties

2.0

01-12NASDAQ.COM

Zentalis Pharmaceuticals (ZNTL) Surges 17.65% as Investors Renew Interest

5.0

01-05Benzinga

Novo Nordisk Launches Wegovy Pill with 17% Average Weight Loss Efficacy

7.5

01-05Yahoo Finance

LifeMD Expands Collaboration with Novo Nordisk to Enhance Offerings

5.0

01-05NASDAQ.COM

LifeMD Launches Wegovy for Weight Management at $149/month

5.0

01-05Globenewswire

LifeMD Launches Wegovy Oral Medication at $149 Monthly Fee

7 Analyst Rating

Wall Street analysts forecast LFMD stock price to rise

6 Buy

1 Hold

0 Sell

Strong Buy

Current: 0.000

Low

6.00

Averages

9.67

High

15.00

Current: 0.000

Low

6.00

Averages

9.67

High

15.00

H.C. Wainwright

Yi Chen

Buy

downgrade

$13 -> $9

AI Analysis

2025-11-19

Reason

H.C. Wainwright

Yi Chen

Price Target

$13 -> $9

AI Analysis

2025-11-19

downgrade

Buy

Reason

H.C. Wainwright analyst Yi Chen lowered the firm's price target on LifeMD to $9 from $13 and keeps a Buy rating on the shares following a top- and bottom-line miss in Q3. LifeMD, which is now a pure-play telehealth and pharmacy platform after the company divested its majority ownership in WorkSimpli, updated its 2025 total revenue guidance and the firm adjusted its projections accordingly, the analyst noted.

KeyBanc

Scott Schoenhaus

Overweight

downgrade

$12 -> $8

2025-11-19

Reason

KeyBanc

Scott Schoenhaus

Price Target

$12 -> $8

2025-11-19

downgrade

Overweight

Reason

KeyBanc analyst Scott Schoenhaus lowered the firm's price target on LifeMD (LFMD) to $8 from $12 and keeps an Overweight rating on the shares. The firm notes LifeMD is being impacted by low-cost compounders despite the FDA outlawing the practice earlier this year. However, KeyBanc expects cash prices for brand-name GLP-1s to continue to come down as well as stricter enforcement against compounders in FY26, which should benefit LifeMD due to its partnerships with Eli Lilly (LLY) and Novo (NVO). The firm also expects the launch of oral Wegovy in early FY26 to drive higher weight management subscribers.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for LFMD

Unlock Now

Valuation Metrics

The current forward P/E ratio for LifeMD Inc (LFMD.O) is -9.78, compared to its 5-year average forward P/E of -19.04. For a more detailed relative valuation and DCF analysis to assess LifeMD Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-19.04

Current PE

-9.78

Overvalued PE

40.29

Undervalued PE

-78.38

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

7.15

Current EV/EBITDA

8.83

Overvalued EV/EBITDA

17.49

Undervalued EV/EBITDA

-3.20

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

1.20

Current PS

0.80

Overvalued PS

2.01

Undervalued PS

0.38

Financials

AI Analysis

Annual

Quarterly

Whales Holding LFMD

Trading Trends

People Also Watch

Frequently Asked Questions

What is LifeMD Inc (LFMD) stock price today?

The current price of LFMD is 2.82 USD — it has increased 5.62

What is LifeMD Inc (LFMD)'s business?

What is the price predicton of LFMD Stock?

Wall Street analysts forecast LFMD stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for LFMD is9.67 USD with a low forecast of 6.00 USD and a high forecast of 15.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is LifeMD Inc (LFMD)'s revenue for the last quarter?

LifeMD Inc revenue for the last quarter amounts to 60.17M USD, increased 12.95

What is LifeMD Inc (LFMD)'s earnings per share (EPS) for the last quarter?

LifeMD Inc. EPS for the last quarter amounts to -0.10 USD, decreased -23.08

How many employees does LifeMD Inc (LFMD). have?

LifeMD Inc (LFMD) has 304 emplpoyees as of March 02 2026.

What is LifeMD Inc (LFMD) market cap?

Today LFMD has the market capitalization of 128.52M USD.

LFMD Overview

LFMD Overview

Events Timeline

News

Valuation Metrics

Forward PE

Forward EV/EBITDA

Forward PS

Financials

Whales Holding LFMD

Trading Trends

People Also Watch

Frequently Asked Questions

What is LifeMD Inc (LFMD) stock price today?

What is LifeMD Inc (LFMD)'s business?

What is the price predicton of LFMD Stock?

What is LifeMD Inc (LFMD)'s revenue for the last quarter?

What is LifeMD Inc (LFMD)'s earnings per share (EPS) for the last quarter?

How many employees does LifeMD Inc (LFMD). have?

What is LifeMD Inc (LFMD) market cap?